- Trials with a EudraCT protocol (103)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
103 result(s) found for: Medial.
Displaying page 1 of 6.
EudraCT Number: 2011-003059-20 | Sponsor Protocol Number: EMR700692_006 | Start Date*: 2013-07-31 | |||||||||||
Sponsor Name:Merck KGaA | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to investigate the efficacy and safety of different intra-articular (i.a.) dosages of sprifermin in subjects with p... | |||||||||||||
Medical condition: Primary osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) EE (Completed) DK (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001096-73 | Sponsor Protocol Number: MIV-711-202 | Start Date*: 2016-09-13 | |||||||||||
Sponsor Name:Medivir AB | |||||||||||||
Full Title: An Open-Label, One-Arm Phase II Extension Study to Evaluate Safety and Tolerability of MIV-711 in Patients with Knee Joint Osteoarthritis | |||||||||||||
Medical condition: Knee Join Osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004581-10 | Sponsor Protocol Number: CL2-201086-002 | Start Date*: 2018-09-04 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-bli... | |||||||||||||
Medical condition: Osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) HU (Completed) DK (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001913-13 | Sponsor Protocol Number: 0524A-041 | Start Date*: 2006-11-29 | |||||||||||
Sponsor Name:Merck & Co., Inc. | |||||||||||||
Full Title: A Worldwide, Double-Blind, Randomized, Placebo-Controlled Study of MK-0524A 2g Coadministered with Intensive LDL-C Lowering Therapy Compared to Intensive LDL-C Lowering Therapy Alone on Carotid Art... | |||||||||||||
Medical condition: heterozygous familial hypercholesterolemia (HeFH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Prematurely Ended) SE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004074-93 | Sponsor Protocol Number: EP005 | Start Date*: 2005-03-01 |
Sponsor Name:EpiTan Limited | ||
Full Title: A Pilot, Phase II, Open, Controlled Study to Evaluate the Safety, Tolerability and Efficacy of a Subcutaneous Implant of Melanotan in Patients Suffering from Recurrent Polymorphous Light Eruption. | ||
Medical condition: Polymorphous Light Eruption (PMLE) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-005049-21 | Sponsor Protocol Number: MRZ-R-201212_01001_N_2 | Start Date*: 2017-01-12 |
Sponsor Name:LLC Merz Pharma, Russia | ||
Full Title: Multi-center Open Comparative Randomized Trial of Clinical and Neurophysiological Efficacy and Safety of Xeomin (Botulinum Toxin Type A) vs. Botox (Complex of Botulinum Toxin Type A and Hemaggluti... | ||
Medical condition: • Cerebral Palsy • Spastic Paraplegia and Hemiparesis • Equine and Equinovarus Foot Deformation | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2007-000479-40 | Sponsor Protocol Number: D1449L00030 | Start Date*: 2007-09-12 |
Sponsor Name:Department of Psychiatry, RWTH Aachen | ||
Full Title: Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology | ||
Medical condition: Bipolar disorder is a common psychiatric disorder which is characterised by manic and depressive states. The mood stabilizing effect of novel antipsychotics seems to be modulation of neuronal plast... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003584-11 | Sponsor Protocol Number: MACT-IBK-2015 | Start Date*: 2015-12-11 | ||||||||||||||||
Sponsor Name:Medical University Innsbruck | ||||||||||||||||||
Full Title: Matrix-associated autologous chrondrocyte transplantation for grade four cartilage lesions of the knee joint - clinical and radiological outcome in correlation to the initial cell count of the cho... | ||||||||||||||||||
Medical condition: Cartilage lesion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023044-32 | Sponsor Protocol Number: DCS-fMRIPanik | Start Date*: 2011-08-10 |
Sponsor Name:Charité Universitaetsmedizin Berlin | ||
Full Title: Mechanisms of action in exposure therapy: Decoding the neural basis of fear extinction and its pharmacological modulation in patients with panic disorder | ||
Medical condition: panic disorder and agoraphobia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002963-92 | Sponsor Protocol Number: CLRX712A12201 | Start Date*: 2020-02-05 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, placebo-controlled, subject and investigator blinded study investigating the safety, tolerability and preliminary efficacy of 8-week treatment with intra-articular LRX712 to regenerat... | |||||||||||||
Medical condition: Cartilage injuries | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004986-15 | Sponsor Protocol Number: Protocol_AFCN_17022019 | Start Date*: 2019-02-18 | |||||||||||||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||||||||||||
Full Title: Ultrasound-guided nerve block of the anterior femoral cutaneous nerves in healthy volunteers | |||||||||||||||||||||||
Medical condition: Pain around the surgical incision after total knee arthroplasty (TKA). The area anesthetized by a combination of nerve block techniques anesthetizing the anterior femoral cutaneous nerves are inve... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008177-57 | Sponsor Protocol Number: AN08/8748 | Start Date*: 2009-06-05 |
Sponsor Name:University of Leeds | ||
Full Title: “What is the ED95 dose of Prilocaine for femoral nerve block using ultrasound?” | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004215-35 | Sponsor Protocol Number: TENPET | Start Date*: 2005-01-19 |
Sponsor Name:Turku PET Centre | ||
Full Title: Influence of muscle specific activation on regional glucose uptake in the human Achilles tendon | ||
Medical condition: The combined forces generated by the triceps surae muscles causes non-uniform strain within the human triceps aponeuroses. This may cause non-uniform tendon force that would result in intratendinou... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002817-22 | Sponsor Protocol Number: AAG-G-H-1624 | Start Date*: 2017-02-09 | |||||||||||||||||||||||||||||||
Sponsor Name:TETEC Tissue Engineering Technologies - AG | |||||||||||||||||||||||||||||||||
Full Title: Prospective, Multicenter, Single-arm Phase III Clinical Trial to Evaluate the Efficacy and Safety of NOVOCART® Inject plus in the Treatment of Cartilage Defects of the Knee | |||||||||||||||||||||||||||||||||
Medical condition: Repair of cartilage defects of the knee (medial or lateral femoral condyle or tibial plateau, trochlea or patella) caused by traumatic events or osteochondritis dissecans (defect size is ≥ 4 and ≤... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: HU (Completed) CZ (Completed) DE (Completed) PL (Completed) LT (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004942-12 | Sponsor Protocol Number: Protokol_MFCN_10102020 | Start Date*: 2020-11-19 | |||||||||||||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||||||||||||
Full Title: Selective ultrasound-guided nerve block of the medial femoral cutaneous nerve in healthy volunteers | |||||||||||||||||||||||
Medical condition: Pain around the surgical incisions after total knee arthroplasty (TKA). The area anesthetized by new nerve block techniques anesthetizing the medial femoral cutaneous nerve are investigated in heal... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001448-29 | Sponsor Protocol Number: 30001 | Start Date*: 2006-09-18 | |||||||||||
Sponsor Name:St Georges Healthcare NHS trust | |||||||||||||
Full Title: A prospective observational cohort study of intra-articular Infliximab in knee mono-arthritis | |||||||||||||
Medical condition: Inflammatory knee mono-arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000473-83 | Sponsor Protocol Number: PET-tau-FACEHBI | Start Date*: 2021-12-15 |
Sponsor Name:Fundació ACE-Institut Català de Neurociències Aplicades | ||
Full Title: PET imaging study of the brain tau deposit in individuals with subjective cognitive decline and mild cognitive impairment: FACEHBI cohort. | ||
Medical condition: Subjective cognitive impairment and mild cognitive decline in evaluation for diagnosis of Alzheimer's Disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002448-21 | Sponsor Protocol Number: ACTIVATEII | Start Date*: 2020-05-26 | ||||||||||||||||
Sponsor Name:Hellenic Institute for the Study of Sepsis | ||||||||||||||||||
Full Title: A RANDOMIZED CLINICAL TRIAL FOR ENHANCED TRAINED IMMUNE RESPONSES THROUGH BACILLUS CALMETTE-GUÉRIN VACCINATION TO PREVENT INFECTIONS ΒΥ COVID-19: THE ACTIVATE II TRIAL | ||||||||||||||||||
Medical condition: Prevention of COVID-19 infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001836-69 | Sponsor Protocol Number: Vort-MCI_001 | Start Date*: 2021-09-17 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Effects of Vortioxetine in Mild Cognitive Impairment measured by Functional Magnetic Resonance Imaging | ||
Medical condition: Mild cognitive impairment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005956-34 | Sponsor Protocol Number: 0822-011 | Start Date*: 2007-03-14 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Ltd | |||||||||||||
Full Title: A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK-0822 in Patients with Osteoarthritis | |||||||||||||
Medical condition: Osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
